Peptides that regulate food intake: glucagon-like peptide 1-(7-36) amide acts at lateral and medial hypothalamic sites to suppress feeding in rats.

Glucagon-like peptide 1-(7-36) amide (GLP-1) potently inhibits rat feeding behavior after central administration. Because third ventricular injection of GLP-1 appeared to be less effective than lateral ventricular injection, we have reexamined this issue. In addition, we attempted to identify brain regions other than the paraventricular nucleus of the hypothalamus that are sensitive toward GLP-1-induced feeding suppression. Finally, we examined the local role of endogenous GLP-1 by specific GLP-1 receptor blockade. After lateral ventricular injection, GLP-1 significantly inhibited food intake of 24-h-fasted rats in a dose-dependent fashion with a minimal effective dose of 1 microg. After third ventricular injection, GLP-1 (1 microg) was similarly effective in suppressing food intake, which extends previous findings. Intracerebral microinjections of GLP-1 significantly suppressed food intake in the lateral (LH), dorsomedial (DMH), and ventromedial hypothalamus (VMH), but not in the medial nucleus of the amygdala. The minimal effective dose of GLP-1 was 0.3 microg at LH sites and 1 microg at DMH or VMH sites. LH microinjections of exendin-(9-39) amide, a GLP-1 receptor antagonist, at 1 or 2.5 microg did not alter feeding behavior in 24-h-fasted rats. In satiated animals, however, a single LH injection of 1 microg exendin-(9-39) amide significantly augmented food intake, but only during the first 20 min (0.6 vs. 0.1 g). With three repeated injections of 2.5 microg exendin-(9-39) amide every 20 min, 1-h food intake was significantly increased by 300%. These data strongly support and extend the concept of GLP-1 as a physiological regulator of food intake in the hypothalamus.

[1]  R. Palmiter,et al.  Response of neuropeptide Y-deficient mice to feeding effectors , 1998, Regulatory Peptides.

[2]  N. Hoosein,et al.  Human glucagon‐like peptides 1 and 2 activate rat brain adenylate cyclase , 1984, FEBS Letters.

[3]  P. Wellman,et al.  Decreased Intake of a Liquid Diet in Nonfood-Deprived Rats Following Intra-PVN Injections of GLP-1 (7–36) Amide , 1997, Pharmacology Biochemistry and Behavior.

[4]  H. Sasaki,et al.  Distribution and molecular forms of glucagon-like peptide in the dog. , 1989, Life sciences.

[5]  N. Kasting.  Criteria for establishing a physiological role for brain peptides. A case in point: the role of vasopressin in thermoregulation during fever and antipyresis , 1989, Brain Research Reviews.

[6]  V. Go,et al.  Release of hypothalamic cholecystokinin in cats: effects of nutrient and volume loading. , 1989, The American journal of physiology.

[7]  A. Joyner,et al.  Glucose intolerance but normal satiety in mice with a null mutation in the glucagon–like peptide 1 receptor gene , 1996, Nature Medicine.

[8]  V. Go,et al.  Brain Regions Where Cholecystokinin Exerts Its Effect on Satiety a , 1994, Annals of the New York Academy of Sciences.

[9]  F. Mora,et al.  Structural Characterization by Affinity Cross‐Linking of Glucagon‐Like Peptide‐1(7–36)Amide Receptor in Rat Brain , 1995, Journal of neurochemistry.

[10]  P. Lambert,et al.  A role for GLP-1(7-36)NH2 in the central control of feeding behaviour , 1993 .

[11]  L. Pellegrino,et al.  stereotaxic atlas of the rat brain , 1967 .

[12]  C. Orskov.  Glucagon-like peptide-1, a new hormone of the entero-insular axis. , 1992, Diabetologia.

[13]  D. Rhie,et al.  Electrical stimulation of the medial amygdala facilitates gastric acid secretion in conscious rats , 1990, Brain Research.

[14]  T. Schoenfeld,et al.  Disruption of appetite but not hunger or satiety following small lesions in the amygdala of rats. , 1981, Journal of comparative and physiological psychology.

[15]  M. Classen,et al.  Glucagon like peptide (GLP)-1-(7–36)-amide suppresses food intake of fasted rats at lateral hypothalamic sites , 1992, Regulatory Peptides.

[16]  P. J. Larsen,et al.  Central administration of GLP-1-(7-36) amide inhibits food and water intake in rats. , 1996, The American journal of physiology.

[17]  K. Mine,et al.  Effects of small amygdaloid lesions on pancreatic exocrine secretion , 1985, Brain Research.

[18]  C. W. Greene.  THE AMERICAN PHYSIOLOGICAL SOCIETY. , 1922, Science.

[19]  T. Yaksh,et al.  An intragastric meal releases the putative satiety factor cholecystokinin from hypothalamic neurons in cats , 1986, Brain Research.

[20]  G. Edwards,et al.  Glucagon-Like Peptide-1 (7–36) Amide Administered into the Third Cerebroventricle Inhibits Water Intake in Rats , 1998, Proceedings of the Society for Experimental Biology and Medicine. Society for Experimental Biology and Medicine.

[21]  A. Steffens,et al.  University of Groningen The Hypothalamus, Intrinsic Connections and Outflow Pathways to the Endocrine System in Relation to the Control of Feeding and Metabolism Luiten, , 2002 .

[22]  Per Brodal,et al.  A stereotaxic atlas of the rat brain L. J. Pellegrino, A. S. Pellegrino & A. J. Cushman. Plenum Press, New York (1979). 122 Figures. £22.50 , 1980, Neuroscience.

[23]  D. Smith,et al.  A role for glucagon-like peptide-1 in the central regulation of feeding , 1996, Nature.

[24]  L. Orci,et al.  Preproglucagon gene expression in pancreas and intestine diversifies at the level of post-translational processing. , 1986, The Journal of biological chemistry.

[25]  S. Bloom,et al.  Repeated Intracerebroventricular Administration of Glucagon-Like Peptide-1-(7-36) Amide or Exendin-(9-39) Alters Body Weight in the Rat* *This work was supported by the United Kingdom Medical Research Council. , 1999, Endocrinology.

[26]  M. Classen,et al.  Neuropeptide Y and food intake in fasted rats: effect of naloxone and site of action , 1991, Brain Research.

[27]  D. Drucker,et al.  Sustained Expression of Exendin-4 Does Not Perturb Glucose Homeostasis, β-Cell Mass, or Food Intake in Metallothionein-Preproexendin Transgenic Mice* , 2000, The Journal of Biological Chemistry.

[28]  G. Wetherill,et al.  Statistical Theory and Methodology in Science and Engineering. , 1962 .

[29]  L. N. Balaam,et al.  Statistical Theory and Methodology in Science and Engineering , 1966 .

[30]  K. Shima,et al.  Identification and localization of glucagon-like peptide-1 and its receptor in rat brain. , 1987, Endocrinology.

[31]  J. Lauder,et al.  Distribution of glucagonlike peptide I (GLP‐I), glucagon, and glicentin in the rat brain: An immunocytochemical study , 1988, The Journal of comparative neurology.

[32]  D. Drucker,et al.  Glucagon gene expression in vertebrate brain. , 1988, The Journal of biological chemistry.

[33]  M. Classen,et al.  Effect of galanin on food intake in rats: involvement of lateral and ventromedial hypothalamic sites. , 1993, The American journal of physiology.

[34]  S. Woods,et al.  Intraventricular GLP-1 reduces short- but not long-term food intake or body weight in lean and obese rats , 1998, Brain Research.

[35]  B Perkins,et al.  Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action. , 2000, Diabetes.

[36]  S. Bloom,et al.  How glucagon-like is glucagon-like peptide-1? , 1984, Diabetologia.

[37]  E. Fonberg.  The role of the hypothalamus and amygdala in food intake, alimentary motivation and emotional reactions. , 1969, Acta biologiae experimentalis.

[38]  J. Morley.  Neuropeptide regulation of appetite and weight. , 1987, Endocrine reviews.

[39]  S. Bloom,et al.  GLUCAGON-LIKE PEPTIDE-1 7-36: A PHYSIOLOGICAL INCRETIN IN MAN , 1987, The Lancet.

[40]  Y. H. Choi,et al.  An interaction between hypothalamic glucagon-like peptide-1 and macronutrient composition determines food intake in rats. , 2001, The Journal of nutrition.

[41]  清水 一郎.  Identification and localization of glucagon-like peptide-1 and its receptor in rat brain , 1987 .

[42]  T. Yaksh,et al.  Sites in the brain at which cholecystokinin octapeptide (CCK-8) acts to suppress feeding in rats: A mapping study , 1990, Neuropharmacology.

[43]  P. J. Larsen,et al.  Distribution of glucagon-like peptide-1 and other preproglucagon-derived peptides in the rat hypothalamus and brainstem , 1997, Neuroscience.

[44]  S. P. Grossman,et al.  Role of the hypothalamus in the regulation of food and water intake. , 1975, Psychological review.

[45]  S. Woods,et al.  University of Groningen Central infusion of GLP-1, but not leptin, produces conditioned taste aversions in rats , 2002 .

[46]  E. Blázquez,et al.  Autoradiographic localization of receptors for glucagon-like peptide-1(7–36) amide in rat brain , 1992, Neuropeptides.

[47]  S. Bloom,et al.  Characterization of glucagon-like peptide-1-(7–36)amide in the hypothalamus , 1989, Brain Research.

[48]  K. Shima,et al.  Identification of Glucagon-Like Peptide-1(7–36) Amide in Rat Brain , 1989, Annals of clinical biochemistry.

[49]  P. J. Larsen,et al.  Distribution of GLP‐1 Binding Sites in the Rat Brain: Evidence that Exendin‐4 is a Ligand of Brain GLP‐1 Binding Sites , 1995, The European journal of neuroscience.

[50]  C. Ørskov.  Glucagon-like peptide-1, a new hormone of the entero-insular axis , 1992, Diabetologia.

[51]  T. Miyoshi,et al.  Printed in U.S.A. Copyright © 1997 by The Endocrine Society Melanin-Concentrating Hormone Acutely Stimulates Feeding, But Chronic Administration Has No Effect on , 2022 .

[52]  S. Kanse,et al.  Identification and characterization of glucagon‐like peptide‐1 7–36 amide‐binding sites in the rat brain and lung , 1988, FEBS letters.

[53]  D. Drucker,et al.  Effects of aging and a high fat diet on body weight and glucose tolerance in glucagon-like peptide-1 receptor -/- mice. , 1998, Endocrinology.

[54]  Guiding principles for research involving animals and human beings. , 2002, American journal of physiology. Cell physiology.

[55]  G. Mogenson,et al.  Alterations in ingestive behaviors after bilateral lesions of the amygdala in the rat , 1975, Physiology & Behavior.